Zatzman M, Fuligni F, Ripsman R, Suwal T, Comitani F, Edward LM, et al. Widespread hypertranscription in aggressive human cancers. Sci Adv. 2022;8:eabn0238.
Google Scholar
Henikoff S, Zheng Y, Paranal RM, Xu Y, Greene JE, Henikoff JG, et al. RNA polymerase II at histone genes predicts outcome in human cancer. Science. 2025;387:737–43.
Google Scholar
Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23:74–88.
Google Scholar
Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer. Cancer Cell. 2021;39:759–78.
Google Scholar
Vervoort SJ, Devlin JR, Kwiatkowski N, Teng M, Gray NS, Johnstone RW. Targeting transcription cycles in cancer. Nat Rev Cancer. 2022;22:5–24.
Google Scholar
Kolodziejczyk A, Sicinski P. Targeting transcriptional cyclin-dependent kinases in cancer. Mol Cancer Ther. 2025;24:1497–510.
Google Scholar
Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell. 2015;163:174–86.
Google Scholar
Wang X, Deng K, Wang C, Li Y, Wang T, Huang Z, et al. Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control. J Enzym Inhib Med Chem. 2020;35:414–23.
Google Scholar
Chantkran W, Hsieh YC, Zheleva D, Frame S, Wheadon H, Copland M. Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML. Cell Death Discov. 2021;7:137.
Google Scholar
Kolupaeva V, Janssens V. PP1 and PP2A phosphatases-cooperating partners in modulating retinoblastoma protein activation. FEBS J. 2013;280:627–43.
Google Scholar
Lai TC, Narwanti I, Sethy B, Tsai CH, Sharma A, Chang JH, et al. A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models. Biomed Pharmacother. 2025;191:118470.
Google Scholar
Zheng H, Qi Y, Hu S, Cao X, Xu C, Yin Z, et al. Identification of Integrator-PP2A complex (INTAC), an RNA polymerase II phosphatase. Science. 2020;370:eabb5872.
Google Scholar
Wang Z, Song A, Tao B, Miao M, Luo YQ, Wang J, et al. The phosphatase PP1 sustains global transcription by promoting RNA polymerase II pause release. Mol Cell. 2024;84:4824–4842.e4827.
Google Scholar
Huang KL, Jee D, Stein CB, Elrod ND, Henriques T, Mascibroda LG, et al. Integrator Recruits Protein Phosphatase 2A to Prevent Pause Release and Facilitate Transcription Termination. Mol Cell. 2020;80:345–358.e349.
Google Scholar
Michael AC, Ryan MS, Benjamin E, Nova F, Kira G-C, Kristopher B, et al. Control of RNA Pol II Speed by PNUTS-PP1 and Spt5 Dephosphorylation Facilitates Termination by a “Sitting Duck Torpedo” Mechanism. Mol Cell. 2019;76:896–908.e894.
Clark AR, Ohlmeyer M. Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. Pharm Ther. 2019;201:181–201.
Google Scholar
Johnson H, Singh A, Raza A, Sha CM, Wang J, Gowda K, et al. Identification of a novel protein phosphatase 2A activator, PPA24, as a potential therapeutic for FOLFOX-resistant colorectal cancer. J Med Chem. 2024;67:18070–89.
Google Scholar
Morita K, He S, Nowak RP, Wang J, Zimmerman MW, Fu C, et al. Retracted: allosteric activators of protein phosphatase 2A display broad antitumor activity mediated by dephosphorylation of MYBL2. Cell. 2020;181:702–715.e720.
Google Scholar
Vervoort SJ, Welsh SA, Devlin JR, Barbieri E, Knight DA, Offley S, et al. The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer. Cell. 2021;184:3143–3162.e3132.
Google Scholar
Jishage M, Roeder RG. Regulation of hepatocyte cell cycle re-entry by RNA polymerase II-associated Gdown1. Cell Cycle. 2020;19:3222–30.
Google Scholar
Espinosa JM. Get back TFIIF, don’t let me Gdown1. Mol Cell. 2012;45:3–5.
Google Scholar
Hu X, Malik S, Negroiu CC, Hubbard K, Velalar CN, Hampton B, et al. A Mediator-responsive form of metazoan RNA polymerase II. Proc Natl Acad Sci Usa. 2006;103:9506–11.
Google Scholar
Jishage M, Malik S, Wagner U, Uberheide B, Ishihama Y, Hu X, et al. Transcriptional regulation by Pol II(G) involving mediator and competitive interactions of Gdown1 and TFIIF with Pol II. Mol Cell. 2012;45:51–63.
Google Scholar
Cheng B, Li T, Rahl PB, Adamson TE, Loudas NB, Guo J, et al. Functional association of Gdown1 with RNA polymerase II poised on human genes. Mol Cell. 2012;45:38–50.
Google Scholar
DeLaney E, Luse DS. Gdown1 associates efficiently with RNA polymerase II after promoter clearance and displaces TFIIF during transcript elongation. PLoS One. 2016;11:e0163649.
Google Scholar
Mullen Davis MA, Guo J, Price DH, Luse DS. Functional interactions of the RNA polymerase II-interacting proteins Gdown1 and TFIIF. J Biol Chem. 2014;289:11143–52.
Google Scholar
Zhu Z, Liu J, Feng H, Zhang Y, Huang R, Pan Q, et al. Overcoming the cytoplasmic retention of GDOWN1 modulates global transcription and facilitates stress adaptation. Elife. 2022;11:e79116.
Google Scholar
Ball CB, Parida M, Santana JF, Spector BM, Suarez GA, Price DH. Nuclear export restricts Gdown1 to a mitotic function. Nucleic Acids Res. 2022;50:1908–26.
Google Scholar
Jishage M, Yu X, Shi Y, Ganesan SJ, Chen WY, Sali A, et al. Architecture of Pol II(G) and molecular mechanism of transcription regulation by Gdown1. Nat Struct Mol Biol. 2018;25:859–67.
Google Scholar
Jishage M, Ito K, Chu CS, Wang X, Yamaji M, Roeder RG. Transcriptional down-regulation of metabolic genes by Gdown1 ablation induces quiescent cell re-entry into the cell cycle. Genes Dev. 2020;34:767–84.
Google Scholar
Urbach L, Wieland L, Penz F, Samuel RD, Küffer S, Klein L, et al. TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Sci Adv. 2025;11:eadu2339.
Google Scholar
Blandino G, Di Agostino S. New therapeutic strategies to treat human cancers expressing mutant p53 proteins. J Exp Clin Cancer Res. 2018;37:30.
Google Scholar
González-Gualda E, Baker AG, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 2021;288:56–80.
Google Scholar
Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679–86.
Google Scholar
Abu-Qare AW, Abou-Donia MB. Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2’-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ Health B Crit Rev. 2001;4:313–32.
Google Scholar
Nabet B, Roberts JM, Buckley DL, Paulk J, Dastjerdi S, Yang A, et al. The dTAG system for immediate and target-specific protein degradation. Nat Chem Biol. 2018;14:431–41.
Google Scholar
Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, et al. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene. 2002;21:8696–704.
Google Scholar
Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946–60.
Google Scholar
Parast S, Wang S, Iwanaszko M, He Y, Olgun DG, Gold S, et al. Defective RNA processing and ELOA-mediated transcriptional elongation in reversible cellular senescence suggest aging by transcription. Mol Cell. 2025;85:4545–4561.e4548.
Google Scholar
Titov DV, Gilman B, He QL, Bhat S, Low WK, Dang Y, et al. XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat Chem Biol. 2011;7:182–8.
Google Scholar
Shibin H, Linna P, Aixia S, Yu-Xin J, Jingdong C, Mengyun W, et al. INTAC endonuclease and phosphatase modules differentially regulate transcription by RNA polymerase II. Mol Cell. 2023;83:1588–1604.e1585.
Zhao X, Xu Y, Wu Y, Zhang H, Shi H, Zhu H, et al. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy. Am J Physiol Endocrinol Metab. 2019;316:e135–e144.
Google Scholar
Lisa C, Reece F, Rozita A, Ananya K, Jordan AH, Aanchal UP, et al. CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence. Mol Cell. 2023;83:4062–4077.e4065.
Reece F, Lisa C, Aanchal UP, Juan Manuel V, Ben Ho P, Tony L, et al. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest. Mol Cell. 2023;83:4047–4061.e4046.
Engeland K. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ. 2018;25:114–32.
Google Scholar
Pentimalli F, Forte IM, Esposito L, Indovina P, Iannuzzi CA, Alfano L, et al. RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines. Oncogene. 2018;37:3657–71.
Google Scholar
Soprano KJ, Purev E, Vuocolo S, Soprano DR. Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid. Oncogene. 2006;25:5315–25.
Google Scholar
Minling G, Haiou L, Jinfang Z. RB functions as a key regulator of senescence and tumor suppression. Semin Cancer Biol. 2025;109:1–7.
Schmitt E, Steyaert A, Cimoli G, Bertrand R. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Cell Death Differ. 1998;5:506–16.
Google Scholar
DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997;151:671–7.
Google Scholar
Ji S, Feng L, Fu Z, Wu G, Wu Y, Lin Y, et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Sci Transl Med. 2023;15:eadg3358.
Google Scholar
Hlavata A, Neuditschko B, Schellhaas U, Plaschka C, Herzog F, Bernecky C. Structure of cytoplasmic RNA polymerase II. Nat Commun. 2026;17:8640.
Schmitzová J, Zhan Y, Rengachari S, Grabbe F, Dybkov O, Urlaub H, et al. Structure of human cytoplasmic Pol II complex explains global transcription repression by Gdown1. Nat Commun. 2026;7:7854.
Bryll AR, Peterson CL. The circular logic of mRNA homeostasis. Transcription. 2023;14:18–26.
Google Scholar
Forouzanfar F, Moreno DF, Mendoza M. Gene-specific transcript buffering revealed by perturbation of coactivator complexes. Sci Adv. 2025;11:eadr1492–eadr1492.
Google Scholar
Williams TD, Michalak EM, Carey KT, Lam EYN, Anderson A, Griesbach E, et al. mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcription. Mol Cell. 2025;85:117–131.e117.
Google Scholar
Ginzberg MB, Chang N, D’Souza H, Patel N, Kafri R, Kirschner MW. Cell size sensing in animal cells coordinates anabolic growth rates and cell cycle progression to maintain cell size uniformity. Elife. 2018;7:e26957.
Google Scholar
Neurohr GE, Terry RL, Lengefeld J, Bonney M, Brittingham GP, Moretto F, et al. Excessive cell growth causes cytoplasm dilution and contributes to senescence. Cell. 2019;176:1083–1097.e1018.
Google Scholar
Foy R, Crozier L, Pareri AU, Valverde JM, Park BH, Ly T, et al. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest. Mol Cell. 2023;83:4047–4061.e4046.
Google Scholar
Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay BC. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene. 1999;18:583–92.
Google Scholar
Derheimer FA, O’Hagan HM, Krueger HM, Hanasoge S, Paulsen MT, Ljungman M. RPA and ATR link transcriptional stress to p53. Proc Natl Acad Sci Usa. 2007;104:12778–83.
Google Scholar
Sun YY, Xiao L, Wang D, Ji YC, Yang YP, Ma R, et al. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53. Int J Oncol. 2017;50:847–52.
Google Scholar
Jayashankar V, Kubiniok P, McCracken AN, Gentry RG, Eckenstein KH, Sernissi L, et al. Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1A. EMBO J. 2025;44:4473–98.
Google Scholar
Bible KC, Kaufmann SH. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. Cancer Res. 1996;56:4856–61.
Google Scholar
Bhat UG, Gartel AL. Differential sensitivity of human colon cancer cell lines to the nucleoside analogs ARC and DRB. Int J Cancer. 2008;122:1426–9.
Google Scholar
Olson CM, Jiang B, Erb MA, Liang Y, Doctor ZM, Zhang Z, et al. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nat Chem Biol. 2018;14:163–70.
Google Scholar
Xue J, Lou X, Ning D, Shao R, Chen G. Mechanism and treatment of α-amanitin poisoning. Arch Toxicol. 2023;97:121–31.
Google Scholar
Wu Y, Kuang D, Zheng L. New mechanisms and clinical significance of the modulation of tumor immune environments. Sci Sin Vitae. 2024;54:1595–602.
Fidel R, Ryan DP, Björn G, Vivek B, Fabian K, Richter AS, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44:W160–W165.
Zhou S, Zhao F, Zhu D, Zhang Q, Dai Z, Wu Z. Coupling of co-transcriptional splicing and 3’ end Pol II pausing during termination in Arabidopsis. Genome Biol. 2023;24:206.
Google Scholar
Turner S. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;1:15–21.
Yang L, Smyth GK, Wei S. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
Google Scholar
Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–9.
Google Scholar
Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based Analysis of ChIP-Seq (MACS). Methods Mol Biol. 2008;1150:81–95.
Amemiya HM, Kundaje A, Boyle AP. The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep. 2019;9:9354.
Google Scholar
Yu G, Wang L-G, He QY. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382–3.
Google Scholar
